0000899243-20-008529.txt : 20200316 0000899243-20-008529.hdr.sgml : 20200316 20200316203102 ACCESSION NUMBER: 0000899243-20-008529 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200312 FILED AS OF DATE: 20200316 DATE AS OF CHANGE: 20200316 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Doberstein Stephen K CENTRAL INDEX KEY: 0001480111 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36281 FILM NUMBER: 20718972 MAIL ADDRESS: STREET 1: 129 ELSIE STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Dicerna Pharmaceuticals Inc CENTRAL INDEX KEY: 0001399529 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205993609 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 33 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 617 621 8097 MAIL ADDRESS: STREET 1: 33 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-03-12 0 0001399529 Dicerna Pharmaceuticals Inc DRNA 0001480111 Doberstein Stephen K C/O DICERNA PHARMACEUTICALS, INC. 33 HAYDEN AVENUE LEXINGTON MA 02421 1 0 0 0 Director Stock Option (Right to Buy) 15.61 2020-03-12 4 A 0 25000 0.00 A 2030-03-11 Common Stock 25000 25000 D This option vests as to one-third of the underlying shares on the one year anniversary of the vesting start date of February 4, 2020 and as to the remaining two-thirds of the shares in eight quarterly installments thereafter, subject in each case to the Reporting Person's continued service on the board of directors of the Issuer through each applicable vesting date. /s/ John B. Green, attorney-in-fact 2020-03-16